Abridge
$315.9M
Funding date
Valuation / Funding
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| February 17, 2025 | Later Stage VC (Series D) | $250.0M | N/A | - |
| February 22, 2024 | Later Stage VC (Series C) | $150.0M | N/A | - |
| October 20, 2023 | Later Stage VC (Series B) | $30.0M | N/A | - |
Current Valuation Metrics
Abridge is currently valued at $5.3B as of June 24, 2025. The company has raised a total of $779.8M in funding across 3 funding rounds.
Capital Efficiency
With a capital efficiency ratio of 6.80x, Abridge has achieved a valuation that is 6.80 times the total capital raised.
What is Abridge Worth in 2026?
Abridge is a leading private company in the Enterprise Systems (Healthcare) sector. Track Abridge's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Abridge Valuation is Determined
Private company valuations like Abridge's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.